Lu Z, Kuang Z, Li B, Song Z, Huang L
Heliyon. 2023; 9(6):e17173.
PMID: 37342569
PMC: 10277587.
DOI: 10.1016/j.heliyon.2023.e17173.
Iannizzi C, Chai K, Piechotta V, Valk S, Kimber C, Monsef I
Cochrane Database Syst Rev. 2023; 5:CD013600.
PMID: 37162745
PMC: 10171886.
DOI: 10.1002/14651858.CD013600.pub6.
Kowsar R, Rahimi A, Sroka M, Mansouri A, Sadeghi K, Bonakdar E
Sci Rep. 2023; 13(1):2138.
PMID: 36747045
PMC: 9901837.
DOI: 10.1038/s41598-023-29364-8.
Iannizzi C, Chai K, Piechotta V, Valk S, Kimber C, Monsef I
Cochrane Database Syst Rev. 2023; 2:CD013600.
PMID: 36734509
PMC: 9891348.
DOI: 10.1002/14651858.CD013600.pub5.
Kosiorek P, Kazberuk D, Hryniewicz A, Milewski R, Stroz S, Stasiak-Barmuta A
Vaccines (Basel). 2022; 10(2).
PMID: 35214792
PMC: 8875391.
DOI: 10.3390/vaccines10020334.
Pathogenic Basis of Thromboinflammation and Endothelial Injury in COVID-19: Current Findings and Therapeutic Implications.
Higashikuni Y, Liu W, Obana T, Sata M
Int J Mol Sci. 2021; 22(21).
PMID: 34769508
PMC: 8584434.
DOI: 10.3390/ijms222112081.
Eosinophil: A Nonnegligible Predictor in COVID-19 Re-Positive Patients.
Li X, Yin D, Yang Y, Bi C, Wang Z, Ma G
Front Immunol. 2021; 12:690653.
PMID: 34394084
PMC: 8358389.
DOI: 10.3389/fimmu.2021.690653.
Original Hosts, Clinical Features, Transmission Routes, and Vaccine Development for Coronavirus Disease (COVID-19).
Wu T, Kang S, Peng W, Zuo C, Zhu Y, Pan L
Front Med (Lausanne). 2021; 8:702066.
PMID: 34295915
PMC: 8291337.
DOI: 10.3389/fmed.2021.702066.
Longitudinal COVID-19 Surveillance and Characterization in the Workplace with Public Health and Diagnostic Endpoints.
Gunawardana M, Breslin J, Cortez Jr J, Rivera S, Webster S, Ibarrondo F
mSphere. 2021; 6(4):e0054221.
PMID: 34232081
PMC: 8386432.
DOI: 10.1128/mSphere.00542-21.
Respiratory care for the critical patients with 2019 novel coronavirus.
Wang Y, Lu M, Yang S, Bien M, Chen Y, Li Y
Respir Med. 2021; 186:106516.
PMID: 34218168
PMC: 8215880.
DOI: 10.1016/j.rmed.2021.106516.
"Long COVID": A case report of persistent symptoms in a patient with prolonged SARS-CoV-2 shedding for over 110 days.
Omololu A, Ojelade B, Ajayi O, Adesomi T, Alade O, Adebisi S
SAGE Open Med Case Rep. 2021; 9:2050313X211015494.
PMID: 34035919
PMC: 8132077.
DOI: 10.1177/2050313X211015494.
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
Piechotta V, Iannizzi C, Chai K, Valk S, Kimber C, Dorando E
Cochrane Database Syst Rev. 2021; 5:CD013600.
PMID: 34013969
PMC: 8135693.
DOI: 10.1002/14651858.CD013600.pub4.
The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis.
Klassen S, Senefeld J, Johnson P, Carter R, Wiggins C, Shoham S
Mayo Clin Proc. 2021; 96(5):1262-1275.
PMID: 33958057
PMC: 7888247.
DOI: 10.1016/j.mayocp.2021.02.008.
Mortality Benefit of Convalescent Plasma in COVID-19: A Systematic Review and Meta-Analysis.
Bansal V, Mahapure K, Mehra I, Bhurwal A, Tekin A, Singh R
Front Med (Lausanne). 2021; 8:624924.
PMID: 33898477
PMC: 8062901.
DOI: 10.3389/fmed.2021.624924.
Characteristics of Viral Shedding Time in SARS-CoV-2 Infections: A Systematic Review and Meta-Analysis.
Yan D, Zhang X, Chen C, Jiang D, Liu X, Zhou Y
Front Public Health. 2021; 9:652842.
PMID: 33816427
PMC: 8017277.
DOI: 10.3389/fpubh.2021.652842.
Assessing the potential impact of transmission during prolonged viral shedding on the effect of lockdown relaxation on COVID-19.
Tepekule B, Hauser A, Kachalov V, Andresen S, Scheier T, Schreiber P
PLoS Comput Biol. 2021; 17(1):e1008609.
PMID: 33513139
PMC: 7875355.
DOI: 10.1371/journal.pcbi.1008609.
Gastrointestinal insights during the COVID-19 epidemic.
Nie K, Yang Y, Deng M, Wang X
World J Clin Cases. 2020; 8(18):3934-3941.
PMID: 33024750
PMC: 7520780.
DOI: 10.12998/wjcc.v8.i18.3934.
Viral Transmission and Clinical Features in Asymptomatic Carriers of SARS-CoV-2 in Wuhan, China.
Tan F, Wang K, Liu J, Liu D, Luo J, Zhou R
Front Med (Lausanne). 2020; 7:547.
PMID: 33015099
PMC: 7461982.
DOI: 10.3389/fmed.2020.00547.
Convalescent Plasma Therapy and Its Effects On COVID-19 Patient Outcomes: A Systematic Review of Current Literature.
Bakhtawar N, Usman M, Khan M
Cureus. 2020; 12(8):e9535.
PMID: 32905148
PMC: 7465934.
DOI: 10.7759/cureus.9535.
Persistent SARS-COV-2 RNA positivity in a patient for 92 days after disease onset: A case report.
Wang J, Hang X, Wei B, Li D, Chen F, Liu W
Medicine (Baltimore). 2020; 99(34):e21865.
PMID: 32846839
PMC: 7447437.
DOI: 10.1097/MD.0000000000021865.
